Prevention of methamphetamine-induced behavioral sensitization in rats by a cyclic AMP phosphodiesterase inhibitor, rolipram

European Journal of Pharmacology

Volumn 312, Issue 2, 1996, Pages 163-170

  Iyo, Masaomi ^a   Bi, Ying ^a   Hashimoto, Kenji ^a   Inada, Toshiya ^a   Fukui, Susumu ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

Author keywords

Behavioral sensitization; cAMP; Methamphetamine; Microdialysis, in vivo; Rolipram

Indexed keywords

CYCLIC AMP; DOPAMINE; METHAMPHETAMINE; PHOSPHODIESTERASE INHIBITOR; ROLIPRAM;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION;

EID: 0030603209     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00479-7     Document Type: Article

References (45)

1. Barnett, J.V., D.S. Segal and R. Kuczenski, 1987, Repeated amphetamine pretreatment alters the responsiveness of striatal dopamine-stimulated adenylate cyclase to amphetamine-induced desensitization, J. Pharmacol. Exp. Ther. 242, 40.
2. Berretta, S., H.A. Robertson and A.M. Graybiel, 1992, Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum, J. Neurophysiol. 68, 767.
3. Christensen, A.V., J. Arnt, J. Hyttel, J.J. Larsen and O. Svendsen, 1984, Pharmacological effects of a specific dopamine D-1 antagonist SCH23390 in comparison with neuroleptics, Life Sci. 34, 1529.
4. 1A dopamine receptors, Proc. Natl. Acad. Sci. USA 91, 12564.
5. 2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats, Brain Res. 487, 267.
6. Drew, K.L. and S.D. Glick, 1990, Role of D-1 and D-2 receptor stimulation in sensitization to amphetamine-induced circling behavior and in expression and extinction of the Pavlovian conditioned response, Psychopharmacology 101, 465.
7. Essman, W.D., P. McGonigle and I. Lucki, 1993, Anatomical differentiation within the nucleus accumbens of the locomotor stimulatory actions of selective dopamine agonists and d-amphetamine, Psychopharmacology 112, 233.
8. 1 dopamine receptor sensitivity within the rat nucleus accumbens, J. Pharmacol. Exp. Ther. 258, 882.
9. 2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis, Brain Res. 546, 40.
10. Iorio, L.C., A. Barnett, F.H. Leiz, V.P. Houser and C.A. Korduba, 1983, SCH23390, a potential benzazepine antipsychotic with unique interaction on dopaminergic systems, J. Pharmacol. Exp. Ther. 226, 462.
11. Iyo, M., Y. Maeda, T. Inada, Kitao, Y., H. Sasaki and S. Fukui, 1995, The effects of a selective cAMP phosphodiesterase inhibitor, rolipram on methamphetamine-induced behavior, Neuropsychopharmacology 13, 33.
12. Kalivas, P.W. and J. Stewart, 1991, Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity, Brain. Res. Rev. 16, 223.
13. Kazahaya, Y., K. Akimoto and S. Otsuki, 1989, Subchronic methamphetamine treatment enhances methamphetamine- or cocaine-induced dopamine efflux in vivo, Biol. Psychiatry. 25, 903.
14. Karler, R., K.T. Finnegan and L.D. Calder, 1993, Blockade of behavioral sensitization to cocaine and amphetamine by inhibitors of protein synthesis, Brain Res. 603, 19.
15. Kebabian, J.W. and D.B. Calne, 1979, Multiple receptors for dopamine, Nature 277, 93.
16. Kehr, W., G. Debus and R. Neumeister, 1985, Effects of rolipram, a novel antidepressant, on monoamine metabolism in rat brain, J. Neural Transm. 63, 1.
17. Lazareno, S., D.B. Marriott and S.R. Nahorski, 1985, Differential effect of selective and nonselective neuroleptics on intracellular and extracellular cyclic AMP accumulation in rat striatal slices, Brain Res. 361, 91.
18. Lowe, J.A. III and J.B Cheng, 1992, The PDE IV family of calcium-independent phosphodiesterase enzymes, Drugs Future 17, 799.
19. Mailman, R.B., D.W. Schulz, M.H. Lewis, L. Staples, H. Rollema and D.L. Dehaven, 1984, SCH23390: a selective D-1 dopamine antagonist with potent D-2 behavioral actions, Eur. J. Pharmacol. 101, 159.
20. Miserendino, M.J. and E.J. Nestler, 1995, Behavioral sensitization to cocaine: modulation by the cyclic AMP system in the nucleus accumbens, Brain Res. 674, 299.
21. Nishikawa, T., N. Mataga, M. Takashima and M. Toru, 1983, Behavioral sensitization and relative hyperresponsiveness of striatat and limbic dopaminergic neurons after repeated methamphetamine treatment, Eur. J. Pharmacol. 88, 190.
22. Norman, A.B., S.Y. Lu, J.M. Klug and R.B. Norgren, 1993, Sensitization of c-fos expression in rat striatum following multiple challenges with D-amphetamine, Brain Res. 603, 125.
23. Ohno, M., H. Yoshida and S. Watanabe, 1994, NMDA receptor-mediated expression of Fos protein in the rat striatum following methamphetamine administration: relation to behavioral sensitization, Brain Res. 665, 135.
24. Post, R.M. and H. Rose, 1976, Increasing effects of repetative cocaine administration in the rat, Nature 260, 731.
25. Randrup, A. and I. Munkvad, 1970, Biochemical, anatomical and psychological investigations of stereotyped behavior induced by amphetamine, in: Amphetamines and Related Compounds, eds. E. Costa and S. Garattini (Raven Press, New York) p. 695.
26. Robinson, T.E. and J.B. Becker, 1986, Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis, Brain Res. Rev. 11, 157.
27. Robinson, T.E., P.A. Jurson, J.A. Bennett and K.M. Bentgen, 1988, Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with ( + )-amphetamine: a microdialysis study in freely moving rats, Brain Res. 462, 211.
28. 1 -stimulated adenylate cyclase activity and calmodulin in rat striatum, J. Pharmacol. Exp. Ther, 255, 197.
29. Sasaki, H., K. Hashimoto, Y. Maeda, T. Inada, Y. Kitao, S. Fukui and M. Iyo, 1995a, Rolipram, a selective c-AMP phosphodiesterase inhibitor suppresses oro-facial dyskinetic movements in rats, Life Sci. 56, 443.
30. Sasaki, H., K. Hashimoto, T. Inada, S. Fukui and M. Iyo, 1995b, Suppression of orofacial movements by rolipram, a cAMP pohosphodiesterase inhibitor, in rats chronically treated with haloperidol, Eur. J. Pharmacol. 282, 71.
31. Schneider, H.H., 1984, Brain cyclic AMP response to phosphodiesterase inhibitors in rats killed by microwave irradiation or decapitation, Biochem. Pharmacol. 33, 1690.
32. Schneider, H.H., R. Schmiechen, M. Brezinski and J. Seidler, 1986, Stereospecific binding of the antidepressant rolipram to brain protein structures, Eur. J. Pharmacol. 127, 105.
33. Seeman, P., 1980, Brain dopamine receptors, Pharmacol. Rev. 32, 229.
34. Segal, D.S. and R. Kuczenski, 1992, In vivo microdialysis reveals a diminished amphetamine-induced DA response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment, Brain Res. 571, 330.
35. Segal, D.S. and A.J. Mandell, 1974, Long-term administration of damphetamine: progressive augmentation of motor activity and stereotypy, Pharmacol. Biochem. Behav. 2, 249.
36. Stewart, J. and P. Vezina, 1989, Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the developement of sensitization to the locomotor activationg effects of systemic amphetamine, Brain Res. 495, 401.
37. Stone, E.A. and S.M. John, 1992, Stress-induced increase of extracellular levels of cyclic AMP in rat cortex, Brain Res. 597, 144.
38. Stoof, J.C. and J.W. Kebabian, 1981, Opposing rotes for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum, Nature 294, 366.
39. 2 dopamine antagonists on development of methamphetamine-induced behavioral sensitizaiton, Psychopharmacology 98, 89.
40. Undie, A.S. and E. Friedman, 1994, Inhibition of dopamine agonist-induced phosphoinositide hydrolysis by concomitant stimulation of cAMP formation in brain slices, J. Neurochem. 63, 222.
41. Vezina, P. and J. Stewart, 1989, The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine, Brain Res. 499, 108.
42. Wachtel, H., 1982, Characteristic behavioral alterations in rats induced by rolipram and other selective adenosine cyclic 3′,5′-monophosphate phosphodiesterase inhibitors, Psychopharmacology 77, 309.
43. Wolf, M.E., F.J. White, R. Nassar, R.J. Brooderson and M.R. Khansa, 1992, Differential developement of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization, J Pharmacol. Exp. Ther. 264, 249.
44. Wolf, M.E., F.J. White and X.T. Hu, 1994, MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine, J Neurosci. 14, 1735.
45. 1 receptor mutant mice. Cell, 79, 945.